What duration of ADT do you recommend for patients with high risk or very high risk prostate cancer who undergo radical prostatectomy, adjuvant RT, and adjuvant docetaxel?
Answer from: Medical Oncologist at Academic Institution
Locally advanced prostate cancer remains a significant clinical challenge. The role of "adjuvant" docetaxel to follow patients receiving primary radiotherapy plus ADT has been tested in at least 5 randomized studies, with RTOG 0521 the only one to my knowledge showing survival benefit (albeit ...
Comments
Medical Oncologist at Cancer Care Specialists/Renown Oncology/UNR Does patients even need post-op radiation( vs sala...
Medical Oncologist at University of Virginia This and other studies continue to call into quest...
Medical Oncologist at Pacific Urol Inst Stop androgen suppressive therapy when the testost...
Does patients even need post-op radiation( vs sala...
This and other studies continue to call into quest...
Stop androgen suppressive therapy when the testost...